Skip to content

Plasma Active Dental Implant

Osseointegration is not a coincidence; it is the result of surface engineering.

Plasma Active Dental Implant
  • 4.42°

    Contact angle — Plasma-Activated Surface

  • 2–3 wks

    Osseointegration time, suitable for early loading

  • 75–85%

    Bone-to-implant contact, observable by week 3

  • >97%

    Clinical success rate

Engineered from collar to apex.

Powerbone implant anatomy: beveled collar, active thread design, spiral groove, double cutting edge and rounded apex

A connection built for stability.

Four connection features work together at the implant platform.

Implant–abutment connection: switch platform, internal conical connection, internal connection and hexagonal connection

Beyond conventional SLA topography.

The Plasma-Activated Surface is developed using advanced plasma technology that goes beyond conventional SLA topography, biologically activating the surface energy.

Plasma Activation

Beyond Conventional SLA Surfaces

Thanks to plasma activation:

  • Hydrocarbon contamination is eliminated.
  • Surface energy is increased to its maximum level.
  • A superhydrophilic surface character is achieved.
  • The contact angle is significantly reduced.
  • Blood and biological fluids spread immediately and uniformly over the surface.
Implant Solution Filling

Active Surface, Preserved Performance

To maintain the superhydrophilic character, the implants are stored in solution. This ensures that:

  • Surface activity remains stable until the moment of clinical application.
  • Atmospheric contamination is prevented.
  • Hydrophilic performance is preserved.

Critical superiority in contact angle.

As clearly demonstrated in the wettability comparison, the Plasma-Activated Surface absorbs the liquid, whereas the conventional SLA surface retains it. A low contact angle means:

  • Rapid fibrin organization
  • Increased protein adsorption
  • Early osteoblast adhesion
Wettability comparison · SLA vs Plasma-Activated

Contact angle by surface treatment

Lower is better

  • 100.276°

    Machined Titanium Surface

    Machined Titanium Surface — 100.276°
  • 70.832°

    Sandblasted Titanium Surface

    Sandblasted Titanium Surface — 70.832°
  • 51.804°

    SLA Surface

    SLA Surface — 51.804°
  • 4.42°

    Plasma-Activated Surface

    Plasma-Activated Surface — 4.42°

Higher surface energy. Lower contact angle. Faster biological initiation.

Every biological advantage gained in the early phase forms the foundation of long-term stability.

From microstructure to macro stability.

The Plasma-Activated Surface ensures maximum contact with the trabecular bone structure. Mechanical retention is enhanced by biological activation. This combination is designed to provide:

  • Increased bone-to-implant contact
  • Strong early stability
  • More predictable osseointegration
From microstructure to macro stability.

Micro-Rough Topography

Surface roughness Ra ≈ 1.5–2.0 µm, an optimal roughness level.

Micro-Rough Topography — 150×

SLA surface vs Plasma-Activated Surface

FeatureSLA SurfacePlasma-Activated Surface
Surface Treatment Technology
SLA Surface

Clinical success rate (sand-blasted, large grit acid-etched) sandblasting with 250–500 grit acid etching.

Plasma-Activated Surface

Following SLA surface treatment (sandblasting with 250–500 µm grit + acid etching), vacuum plasma treatment is applied to create a highly hydrophilic surface and eliminate hydrocarbons.

Surface Roughness (Topography)
SLA Surface

Surface Topography Ra ≈ 1.5–2.0 µm

Plasma-Activated Surface

Surface Topography Ra ≈ 1.5–2.0 µm

Same topography, different surface chemistry

Wettability Contact Angle
SLA Surface

Contact Angle >50°

Hydrophobic

Plasma-Activated Surface

Contact Angle <20°, with active surface preservation through storage in solution.

High hydrophilicity

Initial Cellular Response
SLA Surface

Cell adhesion begins within the first 24–48 hours

Plasma-Activated Surface

Cell attachment and protein adsorption increase within the first 1–4 hours.

Osteoblast Activity
SLA Surface

Osteoblast proliferation increases within 3–7 days.

Plasma-Activated Surface

A marked increase in osteoblast proliferation is observed within 1–3 days.

Faster cellular activation

Osseointegration Process
SLA Surface

Osseointegration time: 4–6 weeks.

Early loading is not recommended.

Plasma-Activated Surface

Osseointegration time: 2–3 weeks

Suitable for early prosthetic loading.

Bone-to-Implant Contact (BIC)
SLA Surface

Bone-to-Implant Contact Percentage 60–70%

Mean value at week 6

Plasma-Activated Surface

Bone-to-Implant Contact Percentage 75–85%

Can be observed even by week 3

Clinical Indications
SLA Surface

Challenging cases: smokers (80–88%), diabetes (85–90%), low bone density (generally 3–6 months), early loading (92–95%)

Plasma-Activated Surface

Challenging cases: smokers (94–96%), diabetes (95%+), low bone density (prosthetic loading possible within 3–4 weeks), early loading (97%+)

Clinical Success Rate
SLA Surface

Clinical success rate >95%

Supported by long-term data

Plasma-Activated Surface

Clinical success rate >97%

Early success and rapid integration

The next level in surface engineering.

See diameters, lengths and every reference code, or request the implant directly.